Does SELUMETINIB Cause Neoplasm progression? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Neoplasm progression have been filed in association with SELUMETINIB (KOSELUGO). This represents 2.1% of all adverse event reports for SELUMETINIB.
25
Reports of Neoplasm progression with SELUMETINIB
2.1%
of all SELUMETINIB reports
2
Deaths
5
Hospitalizations
How Dangerous Is Neoplasm progression From SELUMETINIB?
Of the 25 reports, 2 (8.0%) resulted in death, 5 (20.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELUMETINIB. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does SELUMETINIB Cause?
Blood creatine phosphokinase increased (105)
Rash (89)
Off label use (78)
Paronychia (73)
Dermatitis acneiform (61)
Diarrhoea (59)
Fatigue (54)
Acne (52)
Nausea (49)
Death (47)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which SELUMETINIB Alternatives Have Lower Neoplasm progression Risk?
SELUMETINIB vs SEMAGLUTIDE
SELUMETINIB vs SEMUSTINE
SELUMETINIB vs SENNA LEAF
SELUMETINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SELUMETINIB vs SENNOSIDES